From October 1, 2023 to December 19, 2023, the company has repurchased 2,412,900 shares, representing 0.2% for CNY 38 million. With this, the company has completed the repurchase of 2,412,900 shares, representing 0.2% for CNY 38 million under the buyback announced on August 31, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
12.47 CNY | +3.92% | +0.89% | -15.63% |
06-04 | Yifan Pharmaceutical Gets Nod to Register Phloroglucinol Injection | MT |
05-14 | Yifan Pharmaceutical Unit Gets Authorization to Sell Circulation Supplement in Singapore | MT |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-15.63% | 2.09B | |
+56.89% | 823B | |
+39.52% | 627B | |
-6.55% | 353B | |
+15.99% | 320B | |
+7.92% | 295B | |
+13.74% | 239B | |
+13.83% | 220B | |
-0.49% | 219B | |
+7.94% | 167B |
- Stock Market
- Equities
- 002019 Stock
- News Yifan Pharmaceutical Co., Ltd.
- Tranche Update on Yifan Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on August 31, 2023.